These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Protein Degradation via CRL4 Hansen JD; Condroski K; Correa M; Muller G; Man HW; Ruchelman A; Zhang W; Vocanson F; Crea T; Liu W; Lu G; Baculi F; LeBrun L; Mahmoudi A; Carmel G; Hickman M; Lu CC J Med Chem; 2018 Jan; 61(2):492-503. PubMed ID: 28358507 [TBL] [Abstract][Full Text] [Related]
24. One-Pot Synthesis of Cereblon Proteolysis Targeting Chimeras via Photoinduced C(sp Arndt CM; Bitai J; Brunner J; Opatz T; Martinelli P; Gollner A; Sokol KR; Krumb M J Med Chem; 2023 Dec; 66(24):16939-16952. PubMed ID: 38096359 [TBL] [Abstract][Full Text] [Related]
25. Cereblon suppresses the lipopolysaccharide-induced inflammatory response by promoting the ubiquitination and degradation of c-Jun. Yang J; Huang M; Zhou L; He X; Jiang X; Zhang Y; Xu G J Biol Chem; 2018 Jun; 293(26):10141-10157. PubMed ID: 29748389 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of novel glutarimide ligands for the E3 ligase substrate receptor Cereblon (CRBN): Investigation of their binding mode and antiproliferative effects against myeloma cell lines. Krasavin M; Adamchik M; Bubyrev A; Heim C; Maiwald S; Zhukovsky D; Zhmurov P; Bunev A; Hartmann MD Eur J Med Chem; 2023 Jan; 246():114990. PubMed ID: 36476642 [TBL] [Abstract][Full Text] [Related]
27. A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos. Matyskiela ME; Zhang W; Man HW; Muller G; Khambatta G; Baculi F; Hickman M; LeBrun L; Pagarigan B; Carmel G; Lu CC; Lu G; Riley M; Satoh Y; Schafer P; Daniel TO; Carmichael J; Cathers BE; Chamberlain PP J Med Chem; 2018 Jan; 61(2):535-542. PubMed ID: 28425720 [TBL] [Abstract][Full Text] [Related]
28. [Development of novel cereblon modulators and their target molecules]. Ito T Rinsho Ketsueki; 2022; 63(6):573-579. PubMed ID: 35831190 [TBL] [Abstract][Full Text] [Related]
29. A Degron Blocking Strategy Towards Improved CRL4 Bouguenina H; Scarpino A; O'Hanlon JA; Warne J; Wang HZ; Wah Hak LC; Sadok A; McAndrew PC; Stubbs M; Pierrat OA; Hahner T; Cabry MP; Le Bihan YV; Mitsopoulos C; Sialana FJ; Roumeliotis TI; Burke R; van Montfort RLM; Choudhari J; Chopra R; Caldwell JJ; Collins I Chembiochem; 2023 Dec; 24(23):e202300351. PubMed ID: 37418539 [TBL] [Abstract][Full Text] [Related]
30. UBE2G1 governs the destruction of cereblon neomorphic substrates. Lu G; Weng S; Matyskiela M; Zheng X; Fang W; Wood S; Surka C; Mizukoshi R; Lu CC; Mendy D; Jang IS; Wang K; Marella M; Couto S; Cathers B; Carmichael J; Chamberlain P; Rolfe M Elife; 2018 Sep; 7():. PubMed ID: 30234487 [TBL] [Abstract][Full Text] [Related]
31. Cereblon target validation using a covalent inhibitor of neosubstrate recruitment. Dann GP; Liu H; Nowak RP; Jones LH Methods Enzymol; 2023; 681():155-167. PubMed ID: 36764755 [TBL] [Abstract][Full Text] [Related]
32. Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs. Girardini M; Maniaci C; Hughes SJ; Testa A; Ciulli A Bioorg Med Chem; 2019 Jun; 27(12):2466-2479. PubMed ID: 30826187 [TBL] [Abstract][Full Text] [Related]
34. Cereblon neo-substrate binding mimics the recognition of the cyclic imide degron. Heim C; Spring AK; Kirchgäßner S; Schwarzer D; Hartmann MD Biochem Biophys Res Commun; 2023 Feb; 646():30-35. PubMed ID: 36701892 [TBL] [Abstract][Full Text] [Related]
35. [Cereblon as a primary target of IMiDs]. Ito T; Handa H Rinsho Ketsueki; 2019; 60(9):1013-1019. PubMed ID: 31597822 [TBL] [Abstract][Full Text] [Related]
36. Cereblon modulator CC-885 induces CRBN-dependent ubiquitination and degradation of CDK4 in multiple myeloma. Zhao M; Hu M; Chen Y; Liu H; Chen Y; Liu B; Fang B Biochem Biophys Res Commun; 2021 Apr; 549():150-156. PubMed ID: 33676183 [TBL] [Abstract][Full Text] [Related]
37. Computational investigations of indanedione and indanone derivatives in drug discovery: Indanone derivatives inhibits cereblon, an E3 ubiquitin ligase component. Nayek U; Basheer Ahamed SI; Mansoor Hussain UH; Unnikrishnan MK; Abdul Salam AA Comput Biol Chem; 2022 Dec; 101():107776. PubMed ID: 36252444 [TBL] [Abstract][Full Text] [Related]
38. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2. Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960 [TBL] [Abstract][Full Text] [Related]
39. The E3 ubiquitin ligase component, Cereblon, is an evolutionarily conserved regulator of Wnt signaling. Shen C; Nayak A; Neitzel LR; Adams AA; Silver-Isenstadt M; Sawyer LM; Benchabane H; Wang H; Bunnag N; Li B; Wynn DT; Yang F; Garcia-Contreras M; Williams CH; Dakshanamurthy S; Hong CC; Ayad NG; Capobianco AJ; Ahmed Y; Lee E; Robbins DJ Nat Commun; 2021 Sep; 12(1):5263. PubMed ID: 34489457 [TBL] [Abstract][Full Text] [Related]
40. A mental retardation-linked nonsense mutation in cereblon is rescued by proteasome inhibition. Xu G; Jiang X; Jaffrey SR J Biol Chem; 2013 Oct; 288(41):29573-85. PubMed ID: 23983124 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]